Research programme: metabolic disorders therapeutics - LG Chem
Alternative Names: Cell protectant; GK ActivatorLatest Information Update: 04 Nov 2017
At a glance
- Originator LG Life Sciences
- Developer LG Chem
- Class
- Mechanism of Action Cell modulators; Glucokinase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Metabolic disorders; Type 2 diabetes mellitus
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for research development in Metabolic-disorders in South Korea
- 04 Nov 2017 No recent reports of development identified for research development in Type-2-diabetes-mellitus in South Korea
- 22 Oct 2014 Early research is ongoing in South Korea